A new method for discriminating cerebellar tumors from each other: algorithmic approach

Yıl 2019, , 281 - 288, 28.06.2019

Osman Melih Topcuoğlu

https://doi.org/10.31832/smj.471978

Öz

Objective:
To evaluate the MR imaging findings of the cerebellar tumors (CT) in adults and
to make an algorithm to discriminate these tumors from each other.

Materials
and Methods: Adult patients with CT who were
treated surgically were included. Brain MRs and patient records were evaluated
for pathological diagnosis, imaging findings and Ki-67 labeling index. The
apparent diffusion coefficient (ADC) values of the tumors and centrum semiovale
(CS) and the ratio of each other were noted. Kruskal-Wallis test was used for
comparison.

Results:
100 adults (45 women, 55 men with a mean age of 46.6±15.6
years) with pathologically proven CT were included. Tumors were divided into five
groups as: a. primitive neuro-ectodermal tumor (PNET) + medulloblastoma (MB), b. grade 3+4 gliomas, c. grade 1+2 gliomas, d.
metastasis (MET) and e. lymphoma. The ratio of the mean ADC (x10^-3
mm²/s) of the tumor to those of CS was 1.21±0.22, 1.38±0.93, 1.98±0.69, 1.48±0.45 and 1.25±0.11 for PNET&MBs, grade 3+4 gliomas,
grade 1+2 gliomas, METs and lymphomas, respectively. Significant difference was
detected between grade 1+2 gliomas and PNET&MB (P=0.018), MET (P=0.004) and
lymphoma (P=0.002).

Conclusion:
CT in adults might be differentiated from each other by using some
MR imaging clues and patient characteristics.

Anahtar Kelimeler

Apparent diffusion coefficient, cerebellum, cerebellar tumors

Serebellar Tümörleri Birbirinden Ayırt Etmek İçin Yeni Bir Yöntem: Algoritmik Yaklaşım

Öz

Amaç:
Erişkinlerde serebellar tümörlerin (ST) MR görüntüleme bulgularını inceleyip
birbirlerinden ayrım için algoritmik yaklaşım oluşturabilmek.

Gereç
ve Yöntemler: Çalışmaya, cerrahi olarak tedavi edilmiş ST’li erişkin hastalar
dahil edildi. Beyin MR’ları ve hasta kayıtları
patolojik tanı, görüntüleme bulguları ve Ki-67 indeksi açısından tarandı. Tümöre
ve sentrum semiovale (SS)’ye ait görünür difüzyon katsayıları (GDK) ile
birbirlerine oranları hesaplandı. Karşılaştırma için Kruskal-Wallis testi
kullanıldı.

Bulgular:
Çalışmaya yaş ortalaması 46.6±15.6 yıl olan 100 (45 kadın, 55 erkek) ST’li hasta dahil edildi.
Tümörler 5 gruba ayrıldı: a. primitif nöroektodermal tumor
(PNET)+medulloblastom (MB) b. evre 3+4 gliomlar, c.
evre 1+2 gliomlar, d. metastaz (MET) ve e. lenfoma. PNET&MB, evre 3+4
gliomlar, evre1+2 gliomlar, MET and lenfomalara ait ortalama ST/SS GDK (x10^-3
mm²/s) değerleri sıraıyla1.21±0.22, 1.38±0.93, 1.98±0.69, 1.48±0.45 and 1.25±0.11. Evre 1+2 gliomlar ve PNET&MB’ler (P=0.018), MET (P=0.004) ve lenfomalar (P=0.002)
arasında anlamlı fark vardı.

Sonuç:
Erişkinde ST’ler bazı MR ipuçları ve hasta özellikleri ile birbirlerinden ayırt
edilebilir. 

Anahtar Kelimeler

Görünür difüzyon katsayısı, serebellum, serebellar tümörler

Kaynakça

• Burger PC, Scheithauer BW. Tumors of the Central Nervous System (Afip Atlas of Tumor Pathology) 1 st ed. Washington; 2007.
• Norden AD, Wen PY, Kesari S. Brain metastases. Curr Opin Neurol 2005;18:654-661.
• Sharma V, Prabhash K, Noronha V, Tandon N, Joshi A. A systematic approach to diagnosis of cystic brain lesions. South Asian J Cancer 2013;2:98-101.
• Rumboldt Z, Camacho DL, Lake D, Welsh CT, Castillo M. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006;27:1362-1369.
• Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632-649.
• Ghods AJ, Munoz L, Byrne R. Surgical treatment of cerebellar metastases. Surg Neurol Int 2011;2:159.
• Koeller KK, Rushing EJ. From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 2004;24:1693-1708.
• Johnson DR, Brown PD, Galanis E, Hammack JE. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol. 2012;108:187-193.
• Bonneville F, Sarrazin JL, Marsot-Dupuch K, Iffenecker C, Cordoliani YS, Doyon D, et al. Unusual lesions of the cerebellopontine angle: a segmental approach. Radiographics 2001;21:419-438.
• Slater A, Moore NR, Huson SM. The natural history of cerebellar hemangioblastomas in von Hippel-Lindau disease. AJNR Am J Neuroradiol 2003;24:1570-1574.
• Ho VB, Smirniotopoulos JG, Murphy FM, Rushing EJ. Radiologic-pathologic correlation: hemangioblastoma. AJNR Am J Neuroradiol 1992;13:1343-1352.
• Kulkarni AV, Becker LE, Jay V, Armstrong DC, Drake JM. Primary cerebellar glioblastomas multiforme in children. Report of four cases. J Neurosurg 1999;90:546-550.
• Demir MK, Hakan T, Akinci O, Berkman Z. Primary cerebellar glioblastoma multiforme. Diagn Intervent Radiol 2005;11:83-86.
• Gopalakrishnan CV, Dhakoji A, Nair S, Menon G, Neelima R. A retrospective study of primary cerebellar glioblastoma multiforme in adults. J Clin Neurosci 2012;19(12):1684-1688.
• Katz DS, Poe LB, Winfield JA, Corona RJ, Jr. A rare case of cerebellar glioblastoma multiforme in childhood: MR imaging. Clin Imaging 1995;19:162-164.
• Kuroiwa T, Numaguchi Y, Rothman MI, Zoarski GH, Morikawa M, Zagardo MT, et al. Posterior fossa glioblastoma multiforme: MR findings. AJNR Am J Neuroradiol 1995;16:583-589.
• Partap S, Curran EK, Propp JM, Le GM, Sainani KL, Fisher PG. Medulloblastoma incidence has not changed over time: a CBTRUS study. J Pediatr Hematol Oncol 2009;31:970-971.
• Rodallec M, Colombat M, Krainik A, Kalamarides M, Redondo A, Feydy A. Diffusion-weighted MR imaging and pathologic findings in adult cerebellar medulloblastoma. J Neuroradiol 2004;31:234-237.
• Koeller KK, Rushing EJ. From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. Radiographics 2003;23:1613-1637.
• Koeller KK, Sandberg GD, Armed Forces Institute of P. From the archives of the AFIP. Cerebral intraventricular neoplasms: radiologic-pathologic correlation. Radiographics 2002;22:1473-1505.
• Prince MR, Chew FS. Ependymoma of the fourth ventricle. AJR Am J Roentgenol 1991;157:1278.
• Sanai N, Chang S, Berger MS. Low-grade gliomas in adults. J Neurosurg 2011;115:948-965.
• Kozak KR, Mahadevan A, Moody JS. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome. Neuro Oncol 2009;11:183-191.
• Pakos EE, Goussia AC, Zina VP, Pitouli EJ, Tsekeris PG. Multi-focal gliosarcoma: a case report and review of the literature. J Neuro Oncol 2005;74:301-304.
• Meltzer CC, Smirniotopoulos JG, Jones RV. The striated cerebellum: an MR imaging sign in Lhermitte-Duclos disease (dysplastic gangliocytoma). Radiology 1995;194:699-703.
• Kulkantrakorn K, Awwad EE, Levy B, Selhorst JB, Cole HO, Leake D, et al. MRI in Lhermitte-Duclos disease. Neurology 1997;48:725-731.
• Wei G, Zhang W, Li Q, Kang X, Zhao H, Liu X, et al. Magnetic resonance characteristics of adult-onset Lhermitte-Duclos disease: An indicator for active cancer surveillance? Mol Clin Oncol 2014;2:415-420.
• Kiewe P, Loddenkemper C, Anagnostopoulos I, Reinwald M, Thiel E, Korfel A. High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma. Neuro Oncol 2007;9:96-102.
• Ayuso-Peralta L, Orti-Pareja M, Zurdo-Hernandez M, Jimenez-Jimenez FJ, Tejeiro-Martinez J, Ricoy JR, et al. Cerebral lymphoma presenting as a leukoencephalopathy. J Neurol Neurosurg Psychiatry 2001;71:243-246.